{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:27:46Z","timestamp":1793842066737,"version":"4.6.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Allergic skin diseases, including atopic and contact dermatitis, are prevalent inflammatory disorders imposing clinical and socioeconomic burdens. Their pathogenesis involves impaired barrier function, genetic susceptibility and immune dysregulation, yet mechanistic insights remain limited by the lack of physiologically relevant human in vitro models. Conventional human skin organoids capture aspects of epidermal stratification but generally lack vascular components, limiting tissue maintenance and physiological relevance. To overcome these limitations, vascularized skin assembloids (VSAs) are generated by combining human induced pluripotent stem cell-derived skin organoids with blood vessel organoids under air\u2013liquid interface conditions. This modular assembly supports the formation of key skin-like structural features, including a multilayered epidermis, organized dermal matrix and interconnected vascular-like networks associated with improved barrier maturation and dermal\u2013vascular organization, while providing an accessible platform for epidermal allergen exposure and inflammatory analysis in a vascularized skin-like tissue context. Incorporation of immune cells establishes an immune-integrated and immune-responsive microenvironment that enables modelling of allergen-induced inflammation. Upon exposure to house dust mite extract, VSAs exhibit inflammatory remodelling with atopic dermatitis-relevant features, characterized by barrier disruption, keratinocyte stress responses, immune-cell infiltration and induction of type 2 mediators (IL-4, IL-13, TSLP, CCL17, CCL26). Treatment with clinically used atopic dermatitis therapeutics upadacitinib (JAK1 inhibitor) and dupilumab (IL-4R\u03b1 antagonist) improves barrier-associated features and suppresses STAT6-associated inflammatory signalling, showing responses consistent with their known mechanisms of action. Collectively, these findings support VSAs as a human-relevant, vascularized and immune-integrated skin assembloid model for mechanistic studies and preclinical evaluation of pharmacological responses in inflammatory skin diseases.<\/jats:p>","DOI":"10.1038\/s12276-026-01840-x","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:02:42Z","timestamp":1790812962000},"page":"3339-3356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascularized human skin assembloids model compartmental skin organization and immune responsiveness in vitro"],"prefix":"10.1038","volume":"58","author":[{"given":"Min-Ji","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9322-741X","authenticated-orcid":false,"given":"Kyung-Sun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"1840_CR1","doi-asserted-by":"crossref","unstructured":"Elias, P. M., Wakefield, J. S. Skin barrier function. In: Krutmann, J., Humbert, P. (eds). Nutrition for Healthy Skin: Strategies for Clinical and Cosmetic Practice. 3, 5\u201348 (Springer, 2011).","DOI":"10.1007\/978-3-642-12264-4_4"},{"key":"1840_CR2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","volume":"17","author":"E Proksch","year":"2008","unstructured":"Proksch, E., Brandner, J. M. & Jensen, J. M. The skin: an indispensable barrier. Exp. Dermatol. 17, 1063\u20131072 (2008).","journal-title":"Exp. Dermatol."},{"key":"1840_CR3","doi-asserted-by":"crossref","unstructured":"McGrath, J. A., Uitto, J. Structure and function of the skin. Rook\u2019s Textbook of Dermatology. 1\u201350 (Wiley, 2024).","DOI":"10.1002\/9781119709268.rook002"},{"key":"1840_CR4","volume-title":"Anatomy, Skin (Integument), Epidermis","author":"H Yousef","year":"2017","unstructured":"Yousef, H., Alhajj, M., Sharma, S. Anatomy, Skin (Integument), Epidermis. (StatPearls, 2017)."},{"key":"1840_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2013.12.006","volume":"69","author":"SH Mathes","year":"2014","unstructured":"Mathes, S. H., Ruffner, H. & Graf-Hausner, U. The use of skin models in drug development. Adv. Drug Deliv. Rev. 69, 81\u2013102 (2014).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1840_CR6","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1111\/bph.15184","volume":"177","author":"T Moniz","year":"2020","unstructured":"Moniz, T., Costa Lima, S. A. & Reis, S. Human skin models: from healthy to disease-mimetic systems; characteristics and applications. Br. J. Pharmacol. 177, 4314\u20134329 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"1840_CR7","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1089\/ten.tea.2015.0139","volume":"21","author":"CM Reijnders","year":"2015","unstructured":"Reijnders, C. M. et al. Development of a full-thickness human skin equivalent in vitro model derived from TERT-immortalized keratinocytes and fibroblasts. Tissue Eng. Part A 21, 2448\u20132459 (2015).","journal-title":"Tissue Eng. Part A"},{"key":"1840_CR8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jbiotec.2005.12.021","volume":"122","author":"T Sun","year":"2006","unstructured":"Sun, T., Jackson, S., Haycock, J. W. & MacNeil, S. Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents. J. Biotechnol. 122, 372\u2013381 (2006).","journal-title":"J. Biotechnol."},{"key":"1840_CR9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/ten.tec.2021.0069","volume":"27","author":"P Zoio","year":"2021","unstructured":"Zoio, P., Ventura, S., Leite, M. & Oliva, A. Pigmented full-thickness human skin model based on a fibroblast-derived matrix for long-term studies. Tissue Eng. Part C Methods 27, 433\u2013443 (2021).","journal-title":"Tissue Eng. Part C Methods"},{"key":"1840_CR10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/17460441.2013.761202","volume":"8","author":"P Avci","year":"2013","unstructured":"Avci, P. et al. Animal models of skin disease for drug discovery. Exp. Opin. Drug Discov. 8, 331\u2013355 (2013).","journal-title":"Exp. Opin. Drug Discov."},{"key":"1840_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s10544-017-0156-5","volume":"19","author":"S Lee","year":"2017","unstructured":"Lee, S. et al. Construction of 3D multicellular microfluidic chip for an in vitro skin model. Biomed. Microdevices 19, 22 (2017).","journal-title":"Biomed. Microdevices"},{"key":"1840_CR12","volume":"4","author":"H-G Yi","year":"2017","unstructured":"Yi, H.-G., Lee, H. & Cho, D.-W. 3D printing of organs-on-chips. Bioengineering 4, 10 (2017).","journal-title":"Bioengineering"},{"key":"1840_CR13","volume":"25","author":"S-Y Jung","year":"2022","unstructured":"Jung, S.-Y. et al. Wnt-activating human skin organoid model of atopic dermatitis induced by Staphylococcus aureus and its protective effects by Cutibacterium acnes. Iscience 25, 105150 (2022).","journal-title":"Iscience"},{"key":"1840_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-020-2352-3","volume":"582","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Hair-bearing human skin generated entirely from pluripotent stem cells. Nature 582, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"1840_CR15","volume":"14","author":"M Mostina","year":"2025","unstructured":"Mostina, M. et al. Coordinated development of immune cell populations in vascularized skin organoids from human induced pluripotent stem cells. Adv. Healthc. Mater. 14, e02108 (2025).","journal-title":"Adv. Healthc. Mater."},{"key":"1840_CR16","volume":"15","author":"M-J Kim","year":"2024","unstructured":"Kim, M.-J. et al. Modeling of solar UV-induced photodamage on the hair follicles in human skin organoids. J. Tissue Eng. 15, 20417314241248753 (2024).","journal-title":"J. Tissue Eng."},{"key":"1840_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-018-0858-8","volume":"565","author":"RA Wimmer","year":"2019","unstructured":"Wimmer, R. A. et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature 565, 505\u2013510 (2019).","journal-title":"Nature"},{"key":"1840_CR18","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.stem.2024.09.017","volume":"31","author":"MM Onesto","year":"2024","unstructured":"Onesto, M. M., Kim, J.-I & Pasca, S. P. Assembloid models of cell-cell interaction to study tissue and disease biology. Cell Stem Cell 31, 1563\u20131573 (2024).","journal-title":"Cell Stem Cell"},{"key":"1840_CR19","volume":"15","author":"R Zhou","year":"2025","unstructured":"Zhou, R. et al. Vascularised organoids: recent advances and applications in cancer research. Clin. Transl. Med. 15, e70258 (2025).","journal-title":"Clin. Transl. Med."},{"key":"1840_CR20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116436","volume":"174","author":"D Kong","year":"2024","unstructured":"Kong, D. et al. CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment. Biomed. Pharmacother. 174, 116436 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"1840_CR21","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1038\/s41596-019-0213-z","volume":"14","author":"RA Wimmer","year":"2019","unstructured":"Wimmer, R. A., Leopoldi, A., Aichinger, M., Kerjaschki, D. & Penninger, J. M. Generation of blood vessel organoids from human pluripotent stem cells. Nat. Protoc. 14, 3082\u20133100 (2019).","journal-title":"Nat. Protoc."},{"key":"1840_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02694-y","volume":"13","author":"LT Nguyen","year":"2022","unstructured":"Nguyen, L. T. et al. Optimization of human umbilical cord blood-derived mesenchymal stem cell isolation and culture methods in serum-and xeno-free conditions. Stem Cell Res. Ther. 13, 15 (2022).","journal-title":"Stem Cell Res. Ther."},{"key":"1840_CR23","doi-asserted-by":"crossref","first-page":"C481","DOI":"10.1152\/ajpcell.00147.2020","volume":"319","author":"Z Ma","year":"2020","unstructured":"Ma, Z., Mao, C., Jia, Y., Fu, Y. & Kong, W. Extracellular matrix dynamics in vascular remodeling. Am. J. Physiol. Cell Physiol. 319, C481\u2013C499 (2020).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1840_CR24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.devcel.2013.08.020","volume":"26","author":"M Giannotta","year":"2013","unstructured":"Giannotta, M., Trani, M. & Dejana, E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev. Cell 26, 441\u2013454 (2013).","journal-title":"Dev. Cell"},{"key":"1840_CR25","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1242\/jcs.114.17.3069","volume":"114","author":"A Kalinin","year":"2001","unstructured":"Kalinin, A., Marekov, L. N. & Steinert, P. M. Assembly of the epidermal cornified cell envelope. J. Cell Sci. 114, 3069\u20133070 (2001).","journal-title":"J. Cell Sci."},{"key":"1840_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12079-018-0459-1","volume":"12","author":"MA Cole","year":"2018","unstructured":"Cole, M. A., Quan, T., Voorhees, J. J. & Fisher, G. J. Extracellular matrix regulation of fibroblast function: redefining our perspective on skin aging. J. Cell Commun. Signal. 12, 35\u201343 (2018).","journal-title":"J. Cell Commun. Signal."},{"key":"1840_CR27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1398-9995.2007.01556.x","volume":"63","author":"F Boralevi","year":"2008","unstructured":"Boralevi, F. et al. Epicutaneous aeroallergen sensitization in atopic dermatitis infants \u2014 determining the role of epidermal barrier impairment. Allergy 63, 205\u2013210 (2008).","journal-title":"Allergy"},{"key":"1840_CR28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12016-018-8693-0","volume":"57","author":"JD Miller","year":"2019","unstructured":"Miller, J. D. The role of dust mites in allergy. Clin. Rev. Allergy Immunol. 57, 312\u2013329 (2019).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"1840_CR29","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jid.2024.12.005","volume":"145","author":"R Tandon","year":"2025","unstructured":"Tandon, R. et al. Tralokinumab treatment of atopic dermatitis induces a progressive transcriptomic response. J. Invest. Dermatol. 145, 1643\u20131652.e13 (2025).","journal-title":"J. Invest. Dermatol."},{"key":"1840_CR30","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(21)00588-2","volume":"397","author":"E Guttman-Yassky","year":"2021","unstructured":"Guttman-Yassky, E. et al. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials. Lancet 397, 2151\u20132168 (2021).","journal-title":"Lancet"},{"key":"1840_CR31","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/S0140-6736(21)00589-4","volume":"397","author":"K Reich","year":"2021","unstructured":"Reich, K. et al. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 397, 2169\u20132181 (2021).","journal-title":"Lancet"},{"key":"1840_CR32","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","volume":"75","author":"A Le Floc\u2019h","year":"2020","unstructured":"Le Floc\u2019h, A. et al. Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation. Allergy 75, 1188\u20131204 (2020).","journal-title":"Allergy"},{"key":"1840_CR33","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson, E. L. et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N. Engl. J. Med. 375, 2335\u20132348 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1840_CR34","doi-asserted-by":"crossref","DOI":"10.12703\/r\/10-71","volume":"10","author":"AD Keegan","year":"2021","unstructured":"Keegan, A. D., Leonard, W. J. & Zhu, J. Recent advances in understanding the role of IL-4 signaling. Fac. Rev. 10, 71 (2021).","journal-title":"Fac. Rev."},{"key":"1840_CR35","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221755","volume":"220","author":"M Sharma","year":"2023","unstructured":"Sharma, M. et al. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease. J. Exp. Med. 220, e20221755 (2023).","journal-title":"J. Exp. Med."},{"key":"1840_CR36","volume":"14","author":"Y-C Hsu","year":"2022","unstructured":"Hsu, Y.-C. & Fuchs, E. Building and maintaining the skin. Cold Spring Harb. Perspect. Biol. 14, a040840 (2022).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1840_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1467-2494.2006.00302.x","volume":"28","author":"AV Rawlings","year":"2006","unstructured":"Rawlings, A. V. Ethnic skin types: are there differences in skin structure and function? Int. J. Cosmet. Sci. 28, 79\u201393 (2006).","journal-title":"Int. J. Cosmet. Sci."},{"key":"1840_CR38","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkad014","volume":"11","author":"I Vilela de Sousa","year":"2023","unstructured":"Vilela de Sousa, I. et al. Skin models of cutaneous toxicity, transdermal transport and wound repair. Burns Trauma 11, tkad014 (2023).","journal-title":"Burns Trauma"},{"key":"1840_CR39","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.jid.2024.04.032","volume":"144","author":"C Qu\u00edlez","year":"2024","unstructured":"Qu\u00edlez, C. et al. Targeting the complexity of in vitro skin models: a review of cutting-edge developments. J. Invest. Dermatol. 144, 2650\u20132670 (2024).","journal-title":"J. Invest. Dermatol."},{"key":"1840_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59405-9","volume":"14","author":"CW Chau","year":"2024","unstructured":"Chau, C. W. et al. SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids. Sci. Rep. 14, 8781 (2024).","journal-title":"Sci. Rep."},{"key":"1840_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri.2017.145","volume":"18","author":"Y Huang","year":"2018","unstructured":"Huang, Y. et al. Improving immune\u2013vascular crosstalk for cancer immunotherapy. Nat. Rev. Immunol. 18, 195\u2013203 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1840_CR42","volume":"14","author":"D Kong","year":"2025","unstructured":"Kong, D. et al. In vitro modeling of atherosclerosis using iPSC-derived blood vessel organoids. Adv. Healthc. Mater. 14, 2400919 (2025).","journal-title":"Adv. Healthc. Mater."},{"key":"1840_CR43","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1161\/ATVBAHA.120.314330","volume":"40","author":"Y Shao","year":"2020","unstructured":"Shao, Y. et al. Vascular endothelial cells and innate immunity. Arterioscler. Thromb. Vasc. Biol. 40, e138\u2013e152 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1840_CR44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.801579","volume":"13","author":"M Humeau","year":"2022","unstructured":"Humeau, M., Boniface, K. & Bodet, C. Cytokine-mediated crosstalk between keratinocytes and T cells in atopic dermatitis. Front. Immunol. 13, 801579 (2022).","journal-title":"Front. Immunol."},{"key":"1840_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33114-1","volume":"13","author":"S Sun","year":"2022","unstructured":"Sun, S., Jin, L., Zheng, Y. & Zhu, J. Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform. Nat. Commun. 13, 5481 (2022).","journal-title":"Nat. Commun."},{"key":"1840_CR46","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/cea.13954","volume":"51","author":"JD Hamilton","year":"2021","unstructured":"Hamilton, J. D. et al. Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases. Clin. Exp. Allergy 51, 915\u2013931 (2021).","journal-title":"Clin. Exp. Allergy"},{"key":"1840_CR47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09546634.2019.1577549","volume":"31","author":"MA Rodrigues","year":"2020","unstructured":"Rodrigues, M. A. & Torres, T. JAK\/STAT inhibitors for the treatment of atopic dermatitis. J. Dermatolog. Treat. 31, 33\u201340 (2020).","journal-title":"J. Dermatolog. Treat."},{"key":"1840_CR48","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jamadermatol.2021.3023","volume":"157","author":"A Blauvelt","year":"2021","unstructured":"Blauvelt, A. et al. Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 157, 1047\u20131055 (2021).","journal-title":"JAMA Dermatol."},{"key":"1840_CR49","volume":"2012","author":"M Horiuchi","year":"2012","unstructured":"Horiuchi, M. & Okita, K. Blood flow restricted exercise and vascular function. Int. J. Vasc. Med. 2012, 543218 (2012).","journal-title":"Int. J. Vasc. Med."},{"key":"1840_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45710-4","volume":"15","author":"C Quintard","year":"2024","unstructured":"Quintard, C. et al. A microfluidic platform integrating functional vascularized organoids-on-chip. Nat. Commun. 15, 1452 (2024).","journal-title":"Nat. Commun."},{"key":"1840_CR51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41592-019-0325-y","volume":"16","author":"KA Homan","year":"2019","unstructured":"Homan, K. A. et al. Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat. Methods 16, 255\u2013262 (2019).","journal-title":"Nat. Methods"},{"key":"1840_CR52","volume":"16","author":"RHF Bender","year":"2024","unstructured":"Bender, R. H. F. et al. A vascularized 3D model of the human pancreatic islet for ex vivo study of immune cell-islet interaction. Biofabrication 16, 025001 (2024).","journal-title":"Biofabrication"},{"key":"1840_CR53","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nri2455","volume":"8","author":"M Merad","year":"2008","unstructured":"Merad, M., Ginhoux, F. & Collin, M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 8, 935\u2013947 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1840_CR54","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41588-025-02193-3","volume":"57","author":"MFD Oliveira","year":"2025","unstructured":"Oliveira, M. F. D. et al. High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat. Genet. 57, 1512\u20131523 (2025).","journal-title":"Nat. Genet."},{"key":"1840_CR55","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-024-08002-x","volume":"635","author":"NH Gopee","year":"2024","unstructured":"Gopee, N. H. et al. A prenatal skin atlas reveals immune regulation of human skin morphogenesis. Nature 635, 679\u2013689 (2024).","journal-title":"Nature"},{"key":"1840_CR56","first-page":"257","volume":"42","author":"T Zhang","year":"2024","unstructured":"Zhang, T. et al. 3-D bioprinted human-derived skin organoids accelerate full-thickness skin defects repair. Bioact. Mater. 42, 257\u2013269 (2024).","journal-title":"Bioact. Mater."},{"key":"1840_CR57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf7547","volume":"15","author":"AM Jorgensen","year":"2023","unstructured":"Jorgensen, A. M. et al. Multicellular bioprinted skin facilitates human-like skin architecture in vivo. Sci. Transl. Med. 15, eadf7547 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1840_CR58","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/bit.27320","volume":"117","author":"BS Kwak","year":"2020","unstructured":"Kwak, B. S. et al. Microfluidic skin chip with vasculature for recapitulating the immune response of the skin tissue. Biotechnol. Bioeng. 117, 1853\u20131863 (2020).","journal-title":"Biotechnol. Bioeng."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01840-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:03:33Z","timestamp":1793840613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1840"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01840-x","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.-S.K. and M.-J.K. are inventors on a Korean patent application related to the vascularized skin assembloid technology described in this study (Korean patent application No. 10-2025-0211317, filed on 26 December 2025). The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was carried out in accordance with the approved guidelines of the Seoul National University Institutional Review Board (IRB-No.2504\/003-001, and IRB-No.E2405\/002-021).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}